Mass cytometric analysis of 11 cryopreserved PBMC samples from days 42 to 316 was performed in parallel with control PBMC samples from 5 melanoma patients on anti-PD-1 monotherapy (3 adjuvant and 2 stage III–IV disease) and 7 healthy control subjects (Table 1). Here, PDCD1 is linked to melanoma.